Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126114191 | 12611419 | 1 | I | 20130717 | 20130723 | 20160801 | 20160801 | EXP | DE-ELI_LILLY_AND_COMPANY-19165364 | ELI LILLY AND CO | 59.00 | YR | M | Y | 115.00000 | KG | 20160801 | CN | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126114191 | 12611419 | 1 | PS | CETUXIMAB | CETUXIMAB | 1 | Intravenous (not otherwise specified) | 400 MG/M2, SINGLE | Y | U | 125084 | 400 | MG/M**2 | INJECTION | |||||
126114191 | 12611419 | 2 | SS | CETUXIMAB | CETUXIMAB | 1 | Intravenous (not otherwise specified) | 250 MG/M2, WEEKLY (1/W) | Y | U | 125084 | 250 | MG/M**2 | INJECTION | /wk | ||||
126114191 | 12611419 | 3 | C | 5 FU | FLUOROURACIL | 1 | Intravenous bolus | 2300 MG/M2, EVERY 2 WEEKS | U | 0 | 2300 | MG/M**2 | |||||||
126114191 | 12611419 | 4 | C | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 85 MG/M2, EVERY 2 WEEKS | U | 0 | 85 | MG/M**2 | |||||||
126114191 | 12611419 | 5 | C | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 400 MG/M2, EVERY 2 WEEKS | U | 0 | 400 | MG/M**2 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126114191 | 12611419 | 1 | Colorectal cancer metastatic |
126114191 | 12611419 | 3 | Colorectal cancer metastatic |
126114191 | 12611419 | 4 | Colorectal cancer metastatic |
126114191 | 12611419 | 5 | Colorectal cancer metastatic |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126114191 | 12611419 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126114191 | 12611419 | Angina pectoris | |
126114191 | 12611419 | Febrile neutropenia | |
126114191 | 12611419 | Hypertension | |
126114191 | 12611419 | Influenza | |
126114191 | 12611419 | Lymphopenia | |
126114191 | 12611419 | Nausea | |
126114191 | 12611419 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126114191 | 12611419 | 1 | 20130102 | 20130102 | 0 | |
126114191 | 12611419 | 2 | 20130109 | 20130717 | 0 | |
126114191 | 12611419 | 3 | 20121221 | 0 | ||
126114191 | 12611419 | 4 | 20121221 | 0 | ||
126114191 | 12611419 | 5 | 20121221 | 0 |